New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:40 EDTNTESNetEase.com upgraded to Buy from Neutral at UBS
UBS weekly tracking indicates Q4 game operating metrics have improved significantly and that NetEase's net income could rebound 9% quarter-over-quarter. The firm said NetEase.com's game pipeline is healthy and there is an increasing potential for regular dividends. Price target remains $55.
News For NTES From The Last 14 Days
Check below for free stories on NTES the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2013
10:11 EDTNTESOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:04 EDTNTESNetEase.com upgraded to Overweight from Neutral at HSBC
05:53 EDTNTESNetEase.com upgraded to Buy from Neutral at Citigroup
Citigroup upgraded NetEase.com citing the company's stable revenue growth and raised its price target for shares to $70 from $54.80.
May 15, 2013
18:04 EDTNTESNetEase.com announces annual dividend policy
Subscribe for More Information
18:02 EDTNTESNetEase.com reports Q1 EPS $1.32, consensus $1.20
Reports Q1 revenue $363.6M, consensus $348.13M.
15:11 EDTNTESNotable companies reporting after market close
Subscribe for More Information
May 14, 2013
17:48 EDTNTESLone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES).

Sign up for a free trial to see the rest of the stories you've been missing.